TP53 and cancer: It has been shown to target BCL2L1 and TP53, in consequence cancer cell proliferation was decreased with increased doses of miR-491-5p.38 As mentioned above, disease-related regulation of apoptotic protein-coding transcripts via miRNAs is a well-recognised fact.